Abstract
To investigate the maternal-fetal transfer of tobramycin (TBM) and its distribution in the fetus, a single dose of 2 mg/kg was administered intramuscularly to 35 pregnant patients (13 first trimester, 22 second trimester) 0.5 to 34 h before hysterectomy. TBM concentration was assayed microbiologically in maternal serum, fetal tissues (placenta, brain, lung, liver, and kidney), and fluids (amniotic, cerebrospinal fluid [CSF], urine, and serum). Mean maternal serum half-life (1.54 h) and mean peak serum concentration of TBM were within ranges reported for nonpregnant adults. In fetal serum, half-life was 5.2 h, and TBM levels did not exceed 0.58 μg/ml. For intervals up to 34 h, the mean TBM concentration in placental tissues was 1.4 μg/g. Concentration differences related to fetal maturation were found for fetal CSF, amniotic fluid, and fetal kidney. No antimicrobial activity was found in the fetal CSF of >16 weeks' gestation. TBM was present predominantly in the second trimester amniotic fluid specimens. Fetal kidney concentrations reached 7.2 μg/g at 34 h after maternal drug administration. Higher TBM concentrations were related to advanced maturation of the fetal kidney. Second trimester fetal urine concentrations for TBM ranged from 0.1 to 3.4 μg/ml, and the fetal urinary half-life was 3.7 h. Knowledge of fetal pharmacology is essential for weighing the fetal benefits or risks of antimicrobial therapy for the infected gravid patient.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- BERLIN N. I., GOETSCH C., HYDE G. M., PARSONS R. J. The blood volume in pregnancy as determined by P32 labeled red blood cells. Surg Gynecol Obstet. 1953 Aug;97(2):173–176. [PubMed] [Google Scholar]
- Bennett J. V., Brodie J. L., Benner E. J., Kirby W. M. Simplified, accurate method for antibiotic assay of clinical specimens. Appl Microbiol. 1966 Mar;14(2):170–177. doi: 10.1128/am.14.2.170-177.1966. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Evans C. A., Reynolds J. M., Reynolds M. L., Saunders N. R., Segal M. B. The development of a blood-brain barrier mechanism in foetal sheep. J Physiol. 1974 Apr;238(2):371–386. doi: 10.1113/jphysiol.1974.sp010530. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kaplan J. M., McCracken G. H., Jr, Thomas M. L., Horton L. J., Davis N. Clinical pharmacology of tobramycin in newborns. Am J Dis Child. 1973 May;125(5):656–660. doi: 10.1001/archpedi.1973.04160050012003. [DOI] [PubMed] [Google Scholar]
- Lindheimer M. D., Katz A. I. Pregnancy and the kidney. J Reprod Med. 1973 Jul;11(1):14–18. [PubMed] [Google Scholar]
- Luft F. C., Kleit S. A. Renal parenchymal accumulation of aminoglycoside antibiotics in rats. J Infect Dis. 1974 Dec;130(6):656–659. doi: 10.1093/infdis/130.6.656. [DOI] [PubMed] [Google Scholar]
- Philipson A., Sabath L. D., Charles D. Transplacental passage of erythromycin and clindamycin. N Engl J Med. 1973 Jun 7;288(23):1219–1221. doi: 10.1056/NEJM197306072882307. [DOI] [PubMed] [Google Scholar]
- Ries K., Levison M. E., Kaye D. In vitro evaluation of a new aminoglycoside derivative of kanamycin, a comparison with tobramycin and gentamycin. Antimicrob Agents Chemother. 1973 Apr;3(4):532–533. doi: 10.1128/aac.3.4.532. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Simon V. K., Mösinger E. U., Malerczy V. Pharmacokinetic studies of tobramycin and gentamicin. Antimicrob Agents Chemother. 1973 Apr;3(4):445–450. doi: 10.1128/aac.3.4.445. [DOI] [PMC free article] [PubMed] [Google Scholar]